Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Umberto Restelli
Observed names:
Restelli U,
Restelli, U,
Restelli, Umberto,
U Restelli,
U. Restelli,
Umberto RESTELLI
show all 6
Institution:
University Carlo Cattaneo
Observed institutions:
University of the Witwatersrand,
University Carlo Cattaneo,
Luigi Sacco Hospital,
IRCCS Ospedale Galeazzi - Sant'Ambrogio,
IRCCS Ospedale San Raffaele
ORCID:
0000-0001-6831-3044
Observed ORCID:
0000-0001-6831-3044
OpenAlex ID:
A5025989390
Intraprocedural contrast-enhanced ultrasound (CEUS) in liver percutaneous radiofrequency ablation: clinical impact and health technology assessment
2014
·
Giovanni Mauri
, Emanuele Porazzi
, et al.
·
Insights into Imaging
·
131
Co-Design as Enabling Factor for Patient-Centred Healthcare: A Bibliometric Literature Review
2023
·
Sofia Silvola
, Umberto Restelli
, et al.
·
ClinicoEconomics and Outcomes Research
·
101
PDF
Economic study: a cost-effectiveness analysis of an intraoperative compared with a preoperative image-guided system in lumbar pedicle screw fixation in patients with degenerative spondylolisthesis
2013
·
Francesco Costa
, Emanuele Porazzi
, et al.
·
The Spine Journal
·
39
Economic burden of the management of metastatic castrate-resistant prostate cancer in Italy: a cost of illness study
2017
·
Umberto Restelli
, Giovanni Luca Ceresoli
, et al.
·
Cancer Management and Research
·
28
PDF
Cost-effectiveness of a successful schistosomiasis control programme in Cambodia (1995–2006)
2009
·
Davide Croce
, Emanuele Porazzi
, et al.
·
Acta Tropica
·
28
Cost-effectiveness analysis of the use of letermovir for the prophylaxis of cytomegalovirus in adult cytomegalovirus seropositive recipients undergoing allogenic hematopoietic stem cell transplantation in Italy
2019
·
Umberto Restelli
, Davide Croce
, et al.
·
Infection and Drug Resistance
·
26
PDF
Analysis of errors in histology by root cause analysis: a pilot study
2015
·
Morelli, P
, Porazzi, E
, et al.
·
Journal of preventive medicine and hygiene
·
26
PDF
The Cost of HIV Disease in Northern Italy: The Payer's Perspective
2011
·
Giuliano Rizzardini
, Umberto Restelli
, et al.
·
JAIDS Journal of Acquired Immune Deficiency Syndromes
·
26
Implementation of HCV screening in the 1969–1989 birth‐cohort undergoing COVID‐19 vaccination
2022
·
Roberta D’Ambrosio
, Giuliano Rizzardini
, et al.
·
Liver International
·
25
PDF
New Highly Active Antiretroviral drugs and generic drugs for the treatment of HIV infection: a budget impact analysis on the Italian National Health Service (Lombardy Region, Northern Italy)
2015
·
Umberto Restelli
, Francesca Scolari
, et al.
·
BMC Infectious Diseases
·
24
PDF
What is the impact of SARS-CoV-2 pandemic on antimicrobial stewardship programs (ASPs)? The results of a survey among a regional network of infectious disease centres
2022
·
Agnese Comelli
, Camilla Genovese
, et al.
·
Antimicrobial Resistance and Infection Control
·
23
PDF
Role of Inhaled Methoxyflurane in the Management of Acute Trauma Pain
2020
·
Andrea Fabbri
, Germana Ruggiano
, et al.
·
Journal of Pain Research
·
22
PDF
Cost-utility and budget impact analyses of the use of NEPA for chemotherapy-induced nausea and vomiting prophylaxis in Italy
2017
·
Umberto Restelli
, Gabriella Saibene
, et al.
·
BMJ Open
·
18
PDF
Consequences of inaccurate hepatitis C virus genotyping on the costs of prescription of direct antiviral agents in an Italian district
2016
·
Giustino Parruti
, Ennio Polilli
, et al.
·
ClinicoEconomics and Outcomes Research
·
16
PDF
Cost-Utility Analysis of Lopinavir/Ritonavir versus Atazanavir + Ritonavir Administered as First-Line Therapy for the Treatment of HIV Infection in Italy: From Randomised Trial to Real World
2013
·
Emanuela Foglia
, Paolo Bonfanti
, et al.
·
PLoS ONE
·
16
PDF
Cost-effectiveness analysis of dolutegravir plus backbone compared with raltegravir plus backbone, darunavir+ritonavir plus backbone and efavirenz/tenofovir/emtricitabine in treatment naïve and experienced HIV-positive patients
2017
·
Umberto Restelli
, Giuliano Rizzardini
, et al.
·
Therapeutics and Clinical Risk Management
·
15
PDF
Cost of illness of Primary Biliary Cholangitis - a population-based study
2020
·
Alessio Gerussi
, Umberto Restelli
, et al.
·
Digestive and Liver Disease
·
14
Cost analysis of dalbavancin versus standard of care for the treatment of acute bacterial skin and skin structure infections (ABSSSIs) in two Italian hospitals
2023
·
Francesca Bai
, Maria Mazzitelli
, et al.
·
JAC-Antimicrobial Resistance
·
13
PDF
Assessment of the Costs Related to West Nile Virus Monitoring in Lombardy Region (Italy) between 2014 and 2018
2022
·
Francesco Defilippo
, Michele Dottori
, et al.
·
International Journal of Environmental Research and Public Health
·
13
PDF
COVIDIAGNOSTIX: health technology assessment of serological tests for SARS-CoV-2 infection
2021
·
Rossella Tomaiuolo
, Pietro Derrico
, et al.
·
International Journal of Technology Assessment in Health Care
·
13
PDF
Organisational and financial consequences of the early discharge of patients treated for acute bacterial skin and skin structure infection and osteomyelitis in infectious disease departments in Greece, Italy and Spain: a scenario analysis
2019
·
Umberto Restelli
, Marzia Bonfanti
, et al.
·
BMJ Open
·
11
PDF
Cost-effectiveness analysis of the use of daclatasvir + sofosbuvir + ribavirin (16 weeks and 12 weeks) vs sofosbuvir + ribavirin (16 weeks and 24 weeks) for the treatment of cirrhotic patients affected with hepatitis C virus genotype 3 in Italy
2016
·
Umberto Restelli
, Alfredo Alberti
, et al.
·
The European Journal of Health Economics
·
11
An update on integrase inhibitors: new opportunities for a personalized therapy? The NEXTaim Project.
2015
·
Massimo Andreoni
, Simone Marcotullio
, et al.
·
PubMed
·
11
PDF
Budget impact analysis of antiretroviral less drug regimen simplification in HIV-positive patients on the Italian National Health Service
2014
·
Umberto Restelli
, Massimo Andreoni
, et al.
·
ClinicoEconomics and Outcomes Research
·
11
PDF
Budget impact analysis of the simplification to atazanavir + ritonavir + lamivudine dual therapy of HIV-positive patients receiving atazanavir-based triple therapies in Italy starting from data of the Atlas-M trial
2017
·
Umberto Restelli
, Massimiliano Fabbiani
, et al.
·
ClinicoEconomics and Outcomes Research
·
10
PDF
Show more works
View as search
Works count:
127
Citation count:
788
H-index:
15
I10-index:
26
Year
Topic
Type